Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-<i>ß</i>1/Smad Signalling Pathway.

Ma, Hui; Duan, Xingwu; Zhang, Runtian; Li, Hang; Guo, Yang; Tian, Ye; Huang, Min; Chen, Guangshan; Wang, Zi; Li, Lingling

Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-ß1/Smad Signalling Pathway.

Ma, Hui; Duan, Xingwu; Zhang, Runtian; Li, Hang; Guo, Yang; Tian, Ye; Huang, Min; Chen, Guangshan; Wang, Zi; Li, Lingling.

Afiliación

Ma H; Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, 23 Back Street, Art Museum, Dongcheng District, Beijing 100010, China.
Duan X; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Zhang R; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Li H; Department of Dermatology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China.
Guo Y; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Tian Y; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Huang M; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Chen G; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Wang Z; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.
Li L; Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Shipping Warehouse, Dongcheng District, Beijing 100700, China.

Evid Based Complement Alternat Med ; 2022: 8661288, 2022.

Article en En | MEDLINE | ID: mdl-35873644

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2022 Tipo del documento: Article País de afiliación: China